| 000 | 01874 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250513122419.0 | ||
| 264 | 0 | _c19970805 | |
| 008 | 199708s 0 0 eng d | ||
| 022 | _a0340-7004 | ||
| 024 | 7 |
_a10.1007/s002620050379 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWagner, S N | |
| 245 | 0 | 0 |
_aAnalysis of Pmel17/gp100 expression in primary human tissue specimens: implications for melanoma immuno- and gene-therapy. _h[electronic resource] |
| 260 |
_bCancer immunology, immunotherapy : CII _cJun 1997 |
||
| 300 |
_a239-47 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntibodies, Neoplasm _xanalysis |
| 650 | 0 | 4 | _aAntigens, Neoplasm |
| 650 | 0 | 4 |
_aAntigens, Tumor-Associated, Carbohydrate _xanalysis |
| 650 | 0 | 4 | _aBlotting, Northern |
| 650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
| 650 | 0 | 4 |
_aGenetic Therapy _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 | _aImmunophenotyping |
| 650 | 0 | 4 |
_aImmunotherapy _xmethods |
| 650 | 0 | 4 | _aIn Situ Hybridization |
| 650 | 0 | 4 |
_aMelanoma _ximmunology |
| 650 | 0 | 4 | _aMelanoma-Specific Antigens |
| 650 | 0 | 4 | _aMembrane Glycoproteins |
| 650 | 0 | 4 |
_aNeoplasm Proteins _xanalysis |
| 650 | 0 | 4 |
_aNevus _ximmunology |
| 650 | 0 | 4 | _aProteins |
| 650 | 0 | 4 |
_aRNA, Messenger _xanalysis |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 |
_aSkin Neoplasms _ximmunology |
| 650 | 0 | 4 |
_aT-Lymphocytes, Cytotoxic _ximmunology |
| 650 | 0 | 4 | _aTranscription, Genetic |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 650 | 0 | 4 |
_aUveal Neoplasms _ximmunology |
| 650 | 0 | 4 | _agp100 Melanoma Antigen |
| 700 | 1 | _aWagner, C | |
| 700 | 1 | _aSchultewolter, T | |
| 700 | 1 | _aGoos, M | |
| 773 | 0 |
_tCancer immunology, immunotherapy : CII _gvol. 44 _gno. 4 _gp. 239-47 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s002620050379 _zAvailable from publisher's website |
| 999 |
_c9202547 _d9202547 |
||